Melatonin Promotes Oligodendroglial Maturation of Injured White Matter in Neonatal Rats

Time Factors Cells Science Messenger 610 Nerve Fibers, Myelinated Fluorescence Rats, Sprague-Dawley 03 medical and health sciences Nerve Fibers Animals Developmental Cell Lineage RNA, Messenger Cells, Cultured Melatonin Microscopy 0303 health sciences Cultured Q R Brain Gene Expression Regulation, Developmental Newborn Immunohistochemistry Rats 3. Good health Oligodendroglia Gene Expression Regulation Animals, Newborn Microscopy, Fluorescence Myelinated RNA Medicine Sprague-Dawley Research Article
DOI: 10.1371/journal.pone.0007128 Publication Date: 2009-09-21T18:20:54Z
ABSTRACT
To investigate the effects of melatonin treatment in a rat model of white matter damage (WMD) in the developing brain. Additionally, we aim to delineate the cellular mechanisms of melatonin effect on the oligodendroglial cell lineage.A unilateral ligation of the uterine artery in pregnant rat at the embryonic day 17 induces fetal hypoxia and subsequent growth restriction (GR) in neonatal pups. GR and control pups received a daily intra-peritoneal injection of melatonin from birth to post-natal day (P) 3.Melatonin administration was associated with a dramatic decrease in microglial activation and astroglial reaction compared to untreated GR pups. At P14, melatonin prevented white matter myelination defects with an increased number of mature oligodendrocytes (APC-immunoreactive) in treated GR pups. Conversely, melatonin was not found to be associated with an increased density of total oligodendrocytes (Olig2-immunoreactive), suggesting that melatonin is able to promote oligodendrocyte maturation but not proliferation. These effects appear to be melatonin-receptor dependent and were reproduced in vitro.These data suggest that melatonin has a strong protective effect on developing damaged white matter through decreased microglial activation and oligodendroglial maturation leading to a normalization of the myelination process. Consequently, melatonin should be a considered as an effective neuroprotective candidate not only in perinatal brain damage but also in inflammatory and demyelinating diseases observed in adults.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (85)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....